Back to Agenda
FDA Forum
Session Chair(s)
John Weiner, JD
Associate Director for Policy, Office of Combination Products, OCPP, OC, FDA, United States
The FDA Forum will focus on inter-center collaboration between CDER, CDRH, CBER, and the Office of Combination Products. The recently established Oncology Center of Excellence will be highlighted as a new area of collaboration. FDA representatives will share how they collaborate to provide advice regarding products in development, review marketing applications, and help accelerate medical product approvals.
Learning Objective : Discuss how the various centers in FDA collaborate to provide advice regarding products in development, review marketing applications, and help accelerate medical product approvals.
Speaker(s)
Panelist
Senior Vice President, Molecule Discovery and Head of Infectious Disease, Eli Lilly and Company, United States
Panelist
Acting Deputy Director, Office of Device Evaluation, CDRH , FDA, United States
Panelist
Deputy Center Director for Regulatory Programs CDER, FDA, United States
Panelist
Director, Regulatory Affairs/ Regulatory Policy, Oncology Center of Excellence, FDA, United States
Panelist
Deputy Director, Oncology Center of Excellence, OC, FDA, United States
Have an account?